Affiliation:
1. Department of Pathology (Clinical Microbiology), Hershey Medical Center, Pennsylvania 17033, USA.
Abstract
Agar dilution was used to determine the MICs of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents for 203 penicillin-susceptible and -resistant pneumococci. All pneumococci were inhibited by RPR 106972 at < or = 0.5 microgram/ml. Cefditoren was very active against all pneumococcal groups, with MICs of < or = 2.0 micrograms/ml. Amoxicillin with or without clavulanate was the next most active oral beta-lactam, followed by cefdinir, cefuroxime, cefpodoxime, and cefprozil. U-100592 and U-100766 were very active against all classes of pneumococci, with all MICs < or = 1.0 microgram/ml.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference27 articles.
1. Antimicrobial resistance in Streptococcus pneumoniae: an overview;Appelbaum P. C.;Clin. Infect. Dis.,1992
2. In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. medical centers in 1992 and 1993;Barry A. L.;Antimicrob. Agents Chemother.,1994
3. Berthaud N. Y. Charles A.-M. Gouin B. Méreau J. Rousseau and J.-F. Desnottes. 1995. RPR 106972 a new oral streptogramin: in vitro antibacterial activity abstr. F112 p. 132. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology Washington D.C.
4. Drug-resistant Streptococcus pneumoniae-Kentucky and Tennessee, 1993;Block S.;Morbid. Mortal. Weekly Rep.,1994
5. Emergence of drug-resistant pneumococcal infections in the United States;Breiman R. F.;JAMA,1994
Cited by
74 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献